Ken Griffin Nephros Inc Transaction History
Citadel Advisors LLC
- $618 Billion
- Q3 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Nephros Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 16,545 shares of NEPH stock, worth $72,798. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,545
Previous 11,890
39.15%
Holding current value
$72,798
Previous $48,000
62.5%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding NEPH
# of Institutions
24Shares Held
4.42MCall Options Held
0Put Options Held
0-
Wexford Capital LP Greenwich, CT3.62MShares$15.9 Million2.68% of portfolio
-
Vanguard Group Inc Valley Forge, PA281KShares$1.24 Million0.0% of portfolio
-
Bard Associates Inc Chicago, IL127KShares$559,3320.18% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny82.5KShares$363,0000.0% of portfolio
-
Geode Capital Management, LLC Boston, MA75.9KShares$333,9200.0% of portfolio
About NEPHROS INC
- Ticker NEPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 10,318,800
- Market Cap $45.4M
- Description
- Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water ...